Cardiology Update for Primary Care: Strategies for the Evaluation, Treatment and Prevention of Our Evolving Epidemic of Heart Failure

OVERALL OBJECTIVES: Upon completion of this course, the participant should be able to formulate a practical approach to common cardiac disorders with a special emphasis on heart failure; determine and employ various physical exam techniques as well as appropriate diagnostic tests that should be considered to assess the severity of the patient's problem and make an accurate diagnosis; apply the various treatment options available and recognize when to treat and when to refer cardiac patients. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Recent advances in diagnostic modalities as well as advances in the use of cardiac drugs and devices make it necessary to improve medical competence in Cardiology. This course was designed as an update for all practitioners and physicians responsible for the diagnosis and treatment of cardiac patients at the level of a practicing physician or other licensed practitioner.
+ show speakers and program
NO SPEAKERS MENTIONED

Activity Title: Cardiology Update for Primary Care: Strategies for the Evaluation, Treatment and Prevention
of Our Evolving Epidemic of Heart Failure
Activity Dates: February 4-8, 2013
Presenting Faculty: Ileana L. Piña M.D., M.P.H., F.A.H.A., F.A.C.C. and Hector O. Ventura, M.D., F.A.C.C.,
F.A.C.P., F.A.S.H.

SPECIFIC OBJECTIVES
NARRATIVE DESCRIPTION
Upon completion of this course, the participant should
be able to formulate a practical approach to common
cardiac disorders with a special emphasis on heart
failure; determine and employ various physical exam
techniques as well as appropriate diagnostic tests that
should be considered to assess the severity of the
patient's problem and make an accurate diagnosis;
apply the various treatment options available and
recognize when to treat and when to refer cardiac
patients. This activity is expected to result in
improved competence in making an appropriate
diagnosis and providing effective treatment and
referral or follow-up care with the overall goal of
improving patient outcomes.
The emphasis will be on aligning physician behavior
with current guidelines and evidence-based medicine,
as indicated within each topic’s specific objectives.
Recent advances in diagnostic modalities as well as
advances in the use of cardiac drugs and devices
make it necessary to improve medical competence in
Cardiology. This course was designed as an update
for all practitioners and physicians responsible for the
diagnosis and treatment of cardiac patients at the
level of a practicing physician or other licensed
practitioner.
SPECIFIC OBJECTIVES
Day 1
Pathophysiology of Heart Failure.
Upon completion of this session, the participant
should be able to:
1. Illustrate the pathophysiologic mechanisms of
heart failure.
2. Appraise the presentation and therapy of
preserved systolic function in heart failure.
3. Interpret the role of the renin-angiotensinaldosterone
system.
Cardiovascular Disease Prevention & Treatment in
Women: Update on the AHA Guidelines.
Upon completion of this session, the participant
should be able to:
1. Employ strategies to assess and stratify women
into high risk, at risk, and ideal health categories
for cardiovascular disease (CVD).
2. Design and recommend lifestyle approaches to
the prevention of CVD in women.
3. Review the 2011 Guidelines and approaches to
CVD prevention for patients with hypertension,
lipid abnormalities, and diabetes, with a focus on
effectiveness in practice.
4. Apply the 2011 Guidelines and approach to
pharmacological intervention for women at risk
for cardiovascular events.
5. Differentiate commonly used therapies that
should not be initiated for the prevention or
treatment of CVD, because they lack benefit, or
because risks outweigh benefits.
“Tricks of the Trade”- A Primary Care Approach to
the Patient.
Upon completion of this session, the participant
should be able to:
1. Assess the patient with pathophysiologic
background.
2. Develop innovative history-taking techniques.
3. Plan a physical exam targeted to volume and
cardiac output.
Non-Pharmacologic and Pharmacologic HF
Therapy.
Upon completion of this session, the participant
should be able to:
1. Appraise the evidence in therapy of heart failure.
2. Evaluate the data on the clinical trials of therapy.
3. Relate the role of device therapy.
4. Appraise and differentiate the AHA/ACC
Guidelines with those of the HFSA.
Day 2
Primary and Secondary Prevention of Heart
Failure.
Upon completion of this session, the participant
should be able to:
1. Relate the importance of primary prevention for
coronary artery disease.
2. Appraise clinical trials of lipid lowering agents for
primary and secondary prevention of coronary
artery disease.
3. Determine the importance of rehabilitation and
nonpharmacological treatment from prevention
and treatment of coronary artery disease.
Cardiac Devices for HF.
Upon completion of this session, the participant
should be able to:
1. Relate the impact of contemporary heart failure
therapy.
2. Appraise the principles of ICD use and clinical
indications for patients with heart failure.
3. Specify and relate the benefits of Cardiac
Resynchronization Therapy (CRT).
4. Determine the clinical indications of cardiac
resynchronization (CRT) in patients with heart
failure artery disease.
CME Sponsors: American Medical Seminars, Inc.
Activity Title: Cardiology Update for Primary Care: Strategies for the Evaluation, Treatment and Prevention
of Our Evolving Epidemic of Heart Failure
Activity Dates: February 4-8, 2013
Presenting Faculty: Ileana L. Piña M.D., M.P.H., F.A.H.A., F.A.C.C. and Hector O. Ventura, M.D., F.A.C.C.,
F.A.C.P., F.A.S.H.
www.ams4cme.com
\\ams-server-01\amsfiles\2012-2013(S27A15V10)\27thSeries-Live\2.3Objectives\09-Cardio-Pina-Ventura\PinaVenturaObj.doc 5/22/2012-ac
SPECIFIC OBJECTIVES
The Way CME Should Be®
TM
5. Relate the clinical indications of LVAD in patients
with heart failure.
6. Analyze areas of uncertainty related to CRT.
7. Determine optimal perioperative outcomes of
device therapy.
Medical Management of Varying Degrees of
Failure.
Upon completion of this session, the participant
should be able to:
1. Design approaches to uptitration of evidencebased
therapy.
2. Formulate appropriate management of barriers to
uptitration.
3. Recommend the reduction of diuretics when
appropriate.
4. Apply the data on the use of BNP targeted
therapy.
HF-PEF: Where Do We Stand?
Upon completion of this session, the participant
should be able to:
1. Assess the severity of current or past symptoms.
2. Determine the etiology of heart failure symptoms.
3. Detect reversible aggravating factors.
4. Appraise concomitant conditions that may affect
heart failure and its treatment.
5. Assess the prognosis of the individual patient
with HF-PEF.
6. Predict and plan for possible complications of
therapy.
7. Evaluate the clinical trials of HF-PEF.
Day 3
Exercise and the Heart Failure Patient: Why, Who
and How.
Upon completion of this session, the participant
should be able to:
1. Appropriately prescribe exercise in patients with
heart failure.
2. Appraise the abnormal exercise physiology of the
heart failure patient.
3. Interpret a cardiopulmonary test in the light of
prognosis.
4. Analyze the evidence for the benefits of exercise
in the heart failure patient.
5. Relate the physiologic benefits reported with
exercise in heart failure.
Complications of Pregnancy: A Failed “Stress”
Test Markers of Future Risk and Opportunities.
Upon completion of this session, the participant
should be able to:
1. Determine reproductive health professionals’
unique opportunity to evaluate and manage
cardiovascular risk in women and the importance
of reproductive history in this evaluation.
2. Develop strategies to successfully incorporate
cardiovascular disease prevention into routine
care of women.
3. Recommend approaches to the prevention of
cardiovascular disease in women, including tools
to successfully motivate patients in facing the
challenge of adopting healthier behaviors.
Diversity and Disparities of Care.
Upon completion of this session, the participant
should be able to:
1. Relate the difference between diversity and
disparity.
2. Practice within the scope of cultural sensitivity.
3. Evaluate the data on disparities in healthcare in
the US.
4. Specify the pathophysiologic differences in heart
failure between African Americans and
Caucasians.
5. Assess risk factor differences in Hispanic
patients.
6. Detect healthcare disparities in one’s own
community or practice.
Novel Therapies for HF: Looking at the Syndrome
from Different Perspectives.
Upon completion of this session, the participant
should be able to:
1. Relate the rationale of new and ongoing clinical
trials.
2. Assess the importance of clinical trial outcomes.
3. Apply new clinical trial evidence in practice.
4. Appraise clinical trial methodology that leads to
Guideline development.
Day 4
Hypertension.
Upon completion of this session, using multiple
research trials as well as the current JNC
recommendations, the participant should be able to:
1. Apply the current JNC recommendations for
treatment of hypertension.
2. Develop a rational approach to choosing
appropriate medications for treating
hypertension.
3. Determine when and how to implement an
evaluation for secondary causes of hypertension.
CME Sponsors: American Medical Seminars, Inc.
Activity Title: Cardiology Update for Primary Care: Strategies for the Evaluation, Treatment and Prevention
of Our Evolving Epidemic of Heart Failure
Activity Dates: February 4-8, 2013
Presenting Faculty: Ileana L. Piña M.D., M.P.H., F.A.H.A., F.A.C.C. and Hector O. Ventura, M.D., F.A.C.C.,
F.A.C.P., F.A.S.H.
www.ams4cme.com
\\ams-server-01\amsfiles\2012-2013(S27A15V10)\27thSeries-Live\2.3Objectives\09-Cardio-Pina-Ventura\PinaVenturaObj.doc 5/22/2012-ac
SPECIFIC OBJECTIVES
The Way CME Should Be®
TM
Interactive Case Management.
Upon completion of this session, the participant
should be able to:
1. Assess common clinical presentations of heart
failure.
2. Develop a comprehensive differential and plans
for appropriate testing to make an accurate
diagnosis.
3. Detect volume overload and formulate an
evidence-based plan for management.
4. Integrate the management of a patient with heart
failure with consideration for therapeutic
outcomes or appropriate referral.
Atrial Fibrillation.
Upon completion of this session, the participant
should be able to:
1. Relate the incidence of arrhythmias and sudden
cardiac death in patients with heart failure.
2. Develop a systematic approach to ventricular
arrhythmias.
3. Adapt and use a systematic approach to atrial
fibrillation.
4. Appraise the role of anticoagulation and employ
evidence-based treatment of atrial fibrillation.
5. Select appropriate devices to improve clinical
outcomes.
Quality Improvement in Heart Failure and
Transitions of Care.
Upon completion of this session, the participant
should be able to:
1. Assess the needs of the patient in transition from
hospital to home.
2. Formulate the necessary components of a
successful discharge from home.
3. Specify and employ strategies to decrease
rehospitalization.
Day 5
Disease Management and Telehealth.
Upon completion of this session, the participant
should be able to:
1. Determine which patients are eligible for
telehealth.
2. Appraise and quantify the benefits of telehealth.
3. Contrast and distinguish the differences among
telehealth systems.
4. Formulate protocols for heart failure in home
health.
5. Practice in an environment of collaborative care
with other health professionals.
6. Develop and present education relevant to each
individual patient and caregivers.
End of Life and Palliation in Heart Failure.
Upon completion of this session, the participant
should be able to:
1. Relate the clinical pathway of signs and
symptoms for end-stage heart failure (HF).
2. Detect and appraise the known prognostic
indicators for patients with HF.
3. Distinguish the difference between sudden death
and pump failure and how to discuss each with
patients with HF.
4. Develop a plan for end of life medication
management for HF.
5. Determine the role of device and advanced
therapies for end stage HF.
6. Appraise the important factors to the
multidisciplinary approach to end of life care for
patients with HF.
7. Implement the tools available to predict prognosis
in patients with severe HF.
Interactive Cases.
Upon completion of this session, the participant
should be able to:
1. Assess common clinical presentations of patients
with risk factors for CVD.
2. Develop a comprehensive differential and plans
for appropriate testing to make an accurate
diagnosis.
3. Determine the risk level of individual patients and
formulate an evidence-based plan for
management.
4. Integrate risk factor development and overall
management with consideration for expected
clinical outcomes.
Future Research in Heart Failure.
Upon completion of this session, the participant
should be able to:
1. Relate novel mechanistic approaches to therapy.
2. Analyze on-going clinical trials of heart failure
therapy.
3. Assess the public health issues and the role of
the new health care law.

4 Feb - 8 Feb 2013

Sarasota
United States of America
meeting website